ISSN 1662-4009 (online)

ey0015.2-21 | Overweight PCOS mothers treated with Metformin give birth to offspring with larger heads | ESPEYB15

Overweight PCOS mothers treated with Metformin give birth to offspring with larger heads

A Hjorth-Hansen , Ø Salvesen , LG Engen Hanem , T Eggebø , KÅ Salvesen , E Vanky , RJ Ødegård

To read the full abstract: Clin Endocrinol Metab. 2018 Feb 1;103(2):740-747Polycystic ovary syndrome (PCOS) is characterized by oligo-amenorrhoea, clinical and/or biochemical hyperandrogenism, polycystic ovaries, infertility and, commonly, insulin resistance, hyperinsulinaemia, morbid obesity and type 2 diabetes. The insulin-sensitizing drug metformin ameliorates the endocrinopathy of PCOS by red...

ey0015.3-14 | ATA Scientific statement | ESPEYB15

3.14 American Thyroid Association Scientific Statement on the use of potassium iodide ingestion in a nuclear emergency

AM Leung , AJ Bauer , S Benvenga , AV Brenner , JV Hennessey , JR Hurley , SA Milan , AB Schneider , K Sundaram , DJ Toft

To read the full abstract: Thyroid 2017;27:865-877This very complete paper reviews all available knowledge and information on three main aspects of a nuclear emergency and prevention of thyroid cancer by ingestion of potassium iodide: geographical, legal, logistic and communication aspects are discussed for an optimal protection of the population at risk in case of nuclear emergenc...

ey0015.4-4 | Important for clinical practice | ESPEYB15

4.4 Consensus Based Definition of Growth Restriction in the Newborn

IM Beune , FH Bloomfield , W Ganzevoort , ND Embleton , PJ Rozance , AG van Wassenaer-Leemhuis , K Wynia , SJ Gordijn

To read the full abstract: J Pediatr 2018. 196:71-76Fetal growth restriction describes a fetus who fails to achieve their biological growth potential, remaining smaller than its genetic potential, and occurs in ~10% of pregnancies [22]. FGR and SGA are terms that are often and wrongly used in an interchangeable way. SGA does not inevitably entail a pathological condition, b...

ey0015.4-8 | Novel insights into Silver-Russell syndrome | ESPEYB15

4.8 Targeted next generation sequencing approach in patients referred for Silver-Russell syndrome testing increases the mutation detection rate and provides decisive information for clinical management

R Meyer , L Soellner , M Begemann , S Dicks , G Fekete , N Rahner , K Zerres , M Elbracht , T Eggermann

To read the full abstract: J Pediatr 2017; 187:206-12SRS is a clinically heterogeneous imprinting disorder. Although the understanding of its genetic basis has gradually advanced, about 40% of patients still have an unknown molecular defect. In subjects with unknown etiology, diagnosis is primarily clinical, based upon the Netchine-Harbison scoring system (NH-CSS) [31]. How...

ey0015.5-5 | New genes and gene mutations | ESPEYB15

5.5 Aggrecan Mutations in Nonfamilial Short Stature and Short Stature Without Accelerated Skeletal Maturation

C Tatsi , A Gkourogianni , K Mohnike , D DeArment , S Witchel , AC Andrade , TC Markello , J Baron , O Nilsson , YH Jee

To read the full abstract: J Endocr Soc 2017;1:1006-1011Besides its structural role in the extracellular matrix, aggrecan orchestrates a plethora of key mechanisms in endochondral ossification, such as embryonic morphogen distribution, regular indian hedgehog (IHH) / Sox9 expression and columnar chondrocyte orientation. Thus, homozygous loss-of-function mutations in the ACAN gene, encoding...

ey0015.6-13 | Disorders of Sex Development: New paradigm | ESPEYB15

6.13 A Novel Homozygous Missense Mutation in the FU-CRD2 Domain of the R-spondin1 Gene Associated with Familial 46,XX DSD

Y Naasse , A Bakhchane , H Charoute , F Jennane , J Bignon-Topalovic , A Malki , A Bashamboo , A Barakat , H Rouba , K McElreavey

To read the full abstract: Sex Dev. 2017;11(5-6):269-274[Comments on 6.11, 6.12 and 6.13] Evidence for factors necessary for female sexual development are presented in the above 3 publications. Studies of 46,XX DSD individuals show compiling evidence for factors necessary for female development and to counteract...

ey0015.13-16 | Advances in the Diagnosis and Management of Congenital Hypothyroidism | ESPEYB15

13.16 Incidence of congenital hypothyroidism in China: data from the national newborn screening program, 2013-2015

K Deng , C He , J Zhu , J Liang , X Li , X Xie , P Yu , N Li , Q Li , Y Wang

To read the full abstract: J Pediatr Endocrinol Metab 2018; 31(6):601-608This article summarizes the findings of likely the largest program of neonatal congenital hypothyroidism (CH) screening in the world. This is a truly impressive effort. The overall incidence of CH was 1/2421, in line with other reports that also observed a relatively high incidence of CH in neonates born in Asia. However, a...

ey0015.15-12 | Obesity must be studied separately in men and women | ESPEYB15

15.12 TAp63 contributes to sexual dimorphism in POMC neuron functions and energy homeostasis

C Wang , Y He , P Xu , Y Yang , K Saito , Y Xia , X Yan , A Hinton Jr , C Yan , H Ding

To read the full abstract: Nature Communications 2018;9:1544Obesity prevalence is generally higher in women than in men, and there is also a sex difference in body fat distribution. Sex differences in obesity can be explained in part by the influence of gonadal steroids on body composition and appetite; however, behavioural, and socio-cultural factors may also play a role. Here is th...

ey0020.1-12 | Autoimmune Thyroid Disease | ESPEYB20

1.12. Impact of definitive surgery for Graves' disease on adolescent disease-specific quality of life and psychosocial functioning

S Halada , JA Baran , A Isaza , T Patel , L Sisko , K Kazahaya , NS Adzick , WR Katowitz , L Magee , AJ Bauer

Brief summary: Treatment of GravesÂ’ disease comprises anti-thyroid drugs, radioactive iodine ablation or total thyroidectomy (1,2). While definitive treatment of GravesÂ’ disease is widely used in adults, anti-thyroid drug treatment is often used in the pediatric age group over years (1,2). The presented prospective monocenter study provides detailed information on quality of life of adolescents undergoing total thyroidectomy.Two recent studies ...

ey0020.3-19 | Advances in Growth, Bone Biology, and Mineral Metabolism | ESPEYB20

3.19. The synovial microenvironment suppresses chondrocyte hypertrophy and promotes articular chondrocyte differentiation

M Chau , Z Dou , M Baroncelli , EB Landman , A Bendre , M Kanekiyo , A Gkourogianni , K Barnes , L Ottosson , O Nilsson

In Brief: Growth plate and articular cartilage have similar structures composed of distinct chondrocyte layers but they differ substantially with respect to their function and fate. This study combines transplantation experiments with cell tracing in rat with in vitrostudies to identify a novel mechanism by which synoviocytes act directly on chondrocytes to suppress endochondral and promote articular cartilage at the joint surface.Commentary: Gr...